Experimental drug slows progression of Alzheimer’s: Study
The experimental drug lecanemab has the "potential" to serve as treatment at early stages of Alzheimer's disease, according to new trial results.
- Life
- Published Date: 01:11 | 30 November 2022
- Modified Date: 01:22 | 30 November 2022